Peanut Oral Immunotherapy in Children with High-Threshold Peanut Allergy.
- 2025-02-25
- RCT · n = 73
- NEJM evidence 4(3)
- Scott H Sicherer
- Supinda Bunyavanich
- M Cecilia Berin
- Tracy Lo
- Marion Groetch
- Allison Schaible
- Susan A Perry
- Lisa M Wheatley
- Patricia C Fulkerson
- Helena L Chang
- Mayte Suárez-Fariñas
- Hugh A Sampson
- Julie Wang
- PubMed: 39928078
- DOI: 10.1056/evidoa2400306
- High evidence
- Children
sustained unresponsiveness occurred in 68.4% (26/38) on P-OIT versus 8.6% (3/35) tolerating 9043 mg among those avoiding (between-group difference, 59.9 percentage points; 95% CI, 42.4 to 77.3).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes